These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38520052)

  • 1. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant.
    Chiba Y; Tasaka K; Matsubara K; Mori M; Muraoka M; Hamabata T; Nodomi S; Waki K
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30953. PubMed ID: 38520052
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic immune thrombocytopenia in children with romiplostim.
    Chaturvedi S; McCrae KR
    Lancet; 2016 Jul; 388(10039):4-6. PubMed ID: 27103125
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: Use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia.
    Mahat U; Talati R; Kodish E
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27706. PubMed ID: 30854752
    [No Abstract]   [Full Text] [Related]  

  • 4. Remissions after long-term use of romiplostim for immune thrombocytopenia.
    Marshall AL; Scarpone R; De Greef M; Bird R; Kuter DJ
    Haematologica; 2016 Dec; 101(12):e476-e478. PubMed ID: 27587382
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
    Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
    Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
    [No Abstract]   [Full Text] [Related]  

  • 6. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura.
    Gardiner EE; Thom JY; Al-Tamimi M; Hughes A; Berndt MC; Andrews RK; Baker RI
    Br J Haematol; 2010 May; 149(4):625-8. PubMed ID: 20148887
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura.
    Atkinson K
    Clin J Oncol Nurs; 2019 Apr; 23(2):212-216. PubMed ID: 30880797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage therapy of autoimmune thrombocytopenic purpura revealing non-Hodgkin lymphoma by the thrombopoietin receptor agonist romiplostim.
    Al-Nawakil C; Park S; Chapuis N; Dreyfus F; Szwebel TA; Gibault L; Molina T; Hermine O; Bouscary D; Tamburini J
    Br J Haematol; 2012 Jan; 156(1):145-7. PubMed ID: 21848881
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy.
    Patil AS; Dotters-Katz SK; Metjian AD; James AH; Swamy GK
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):483-485. PubMed ID: 23884268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim.
    Al-Samkari H; Schifferli A; Gonzalez-Lopez TJ
    Br J Haematol; 2024 Apr; 204(4):1143-1145. PubMed ID: 38319005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy.
    Decroocq J; Marcellin L; Le Ray C; Willems L
    Obstet Gynecol; 2014 Aug; 124(2 Pt 2 Suppl 1):481-483. PubMed ID: 25004319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
    Magnano L; Enríquez H; Esteve J; Cervera R; Espinosa G
    J Rheumatol; 2014 Sep; 41(9):1895-6. PubMed ID: 25179983
    [No Abstract]   [Full Text] [Related]  

  • 13. Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period.
    Patras A; Figueroa R; Singh AP; Madan I
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients.
    Yoon JS; Lee YJ; Baek DW; Park HY; Park BE; Moon JH; Sohn SK
    Korean J Intern Med; 2018 Mar; 33(2):435-437. PubMed ID: 26947025
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
    Mori M; Kato M; Koh K; Hanada R
    Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.
    Raval JS; Redner RL; Kiss JE
    J Clin Apher; 2013 Aug; 28(4):321-4. PubMed ID: 23450778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITP, interrupted.
    Stasi R
    Blood; 2011 Oct; 118(16):4297-8. PubMed ID: 22021448
    [No Abstract]   [Full Text] [Related]  

  • 19. High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.
    Seidel MG; Urban C; Sipurzynski J; Beham-Schmid C; Lackner H; Benesch M
    Br J Haematol; 2014 May; 165(3):419-21. PubMed ID: 24484542
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
    Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.